Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link. Two out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 22 points (-0.1%) at 16,065 as of Monday, Dec. 2, 2013, 11:45 AM ET. The NYSE advances/declines ratio sits at 1,030 issues advancing vs. 1,883 declining with 116 unchanged. The Insurance industry currently sits up 0.1% versus the S&P 500, which is unchanged. TheStreet would like to highlight 3 stocks pushing the industry lower today: 3. Chubb ( CB) is one of the companies pushing the Insurance industry lower today. As of noon trading, Chubb is down $0.75 (-0.8%) to $95.70 on average volume. Thus far, 604,188 shares of Chubb exchanged hands as compared to its average daily volume of 908,400 shares. The stock has ranged in price between $95.37-$96.45 after having opened the day at $96.35 as compared to the previous trading day's close of $96.45. The Chubb Corporation, through its subsidiaries, provides property and casualty insurance to businesses and individuals. Chubb has a market cap of $24.5 billion and is part of the financial sector. The company has a P/E ratio of 13.5, below the S&P 500 P/E ratio of 17.7. Shares are up 29.2% year to date as of the close of trading on Friday. Currently there are 5 analysts that rate Chubb a buy, no analysts rate it a sell, and 10 rate it a hold. TheStreet Ratings rates Chubb as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, growth in earnings per share and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Chubb Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.